Centre for International Health, University of Bergen, Årstadveien 21, N-5009 Bergen, Norway.
BMC Pediatr. 2011 Feb 2;11:9. doi: 10.1186/1471-2431-11-9.
Calprotectin is a calcium and zinc binding protein, abundant in neutrophils and is extremely stable in faeces. Faecal calprotectin is used as a non-specific marker for gastrointestinal inflammation. It has a good diagnostic precision to distinguish between irritable bowel syndrome and inflammatory bowel disease. Studies have established normal concentrations in healthy children; all these studies have been performed in high-income countries. The objective of this study was to determine the concentration of faecal calprotectin in apparently healthy children aged 0-12 years in urban Kampala, Uganda.
We tested 302 apparently healthy children aged, age 0-12 years (162 female, 140 male) in urban Kampala, Uganda. The children were recruited consecutively by door-to-door visits. Faecal calprotectin was analyzed using a quantitative enzyme-linked immunosorbent assay. Faeces were also tested for Helicobacter pylori (H. pylori) antigen, for growth of enteropathogens and microscopy was performed to assess protozoa and helminths. A short standardized interview with socio-demographic information and medical history was obtained to assess health status of the children.
In the different age groups the median faecal calprotectin concentrations were 249 mg/kg in 0 < 1 year (n = 54), 75 mg/kg in 1 < 4 years (n = 89) and 28 mg/kg in 4 < 12 years (n = 159). There was no significant difference in faecal calprotectin concentrations and education of female caretaker, wealth index, gender, habits of using mosquito nets, being colonized with H. pylori or having other pathogens in the stool.
Concentrations of faecal calprotectin among healthy children, living in urban Ugandan, a low-income country, are comparable to those in healthy children living in high-income countries. In children older than 4 years, the faecal calprotectin concentration is low. In healthy infants faecal calprotectin is high. The suggested cut-off concentrations in the literature can be used in apparently healthy Ugandan children. This finding also shows that healthy children living under poor circumstances do not have a constant inflammation in the gut. We see an opportunity to use this relatively inexpensive test for further understanding and investigations of gut inflammation in children living in low-income countries.
钙卫蛋白是一种富含于中性粒细胞的钙和锌结合蛋白,在粪便中极其稳定。粪便钙卫蛋白可用作胃肠道炎症的非特异性标志物。它具有很好的诊断精度,可以区分肠易激综合征和炎症性肠病。已有研究确定了健康儿童的正常浓度;所有这些研究都是在高收入国家进行的。本研究旨在确定乌干达坎帕拉市区 0-12 岁健康儿童的粪便钙卫蛋白浓度。
我们对乌干达坎帕拉市区 302 名年龄在 0-12 岁(162 名女性,140 名男性)的看似健康的儿童进行了测试。这些儿童是通过挨家挨户的方式招募的。使用定量酶联免疫吸附试验分析粪便钙卫蛋白。还检测了粪便幽门螺杆菌(H. pylori)抗原,以检测肠道病原体的生长,并进行显微镜检查以评估原生动物和寄生虫。通过简短的标准化访谈获取社会人口统计学信息和病史,以评估儿童的健康状况。
在不同年龄组中,0 < 1 岁的儿童中位数粪便钙卫蛋白浓度为 249 mg/kg(n = 54),1 < 4 岁的儿童为 75 mg/kg(n = 89),4 < 12 岁的儿童为 28 mg/kg(n = 159)。女性看护人的教育程度、财富指数、性别、使用蚊帐习惯、是否被幽门螺杆菌定植或粪便中是否存在其他病原体与粪便钙卫蛋白浓度无显著差异。
生活在乌干达这样一个低收入国家的城市健康儿童的粪便钙卫蛋白浓度与生活在高收入国家的健康儿童相当。在 4 岁以上的儿童中,粪便钙卫蛋白浓度较低。在健康婴儿中,粪便钙卫蛋白含量较高。文献中建议的截断值可用于乌干达健康儿童。这一发现还表明,生活在贫困环境中的健康儿童的肠道没有持续的炎症。我们认为有机会利用这种相对廉价的检测方法,进一步了解和研究生活在低收入国家的儿童的肠道炎症。